How have PTIX shares performed in 2024?

Protagenic Therapeutics' stock was trading at $0.99 at the beginning of 2024. Since then, PTIX stock has increased by 30.3% and is now trading at $1.29. View the best growth stocks for 2024 here .

When is Protagenic Therapeutics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our PTIX earnings forecast .

How were Protagenic Therapeutics' earnings last quarter?

Protagenic Therapeutics, Inc. (NASDAQ:PTIX) released its quarterly earnings results on Tuesday, November, 16th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.03.

How do I buy shares of Protagenic Therapeutics?

Shares of PTIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:PTIX

Protagenic Therapeutics (PTIX) Stock Price, News & Analysis

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Free PTIX Stock Alerts

$1.29

-0.08 (-5.84%)

(As of 04/19/2024 ET)

Compare

Today's Range: $1.25
▼
$1.39
50-Day Range: $0.88
▼
$1.82
52-Week Range: $0.68
▼
$2.32

Volume: 4,290 shs
Average Volume: 9,248 shs
Market Capitalization: $5.73 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get Protagenic Therapeutics alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Protagenic Therapeutics Stock (NASDAQ:PTIX)

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company's lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.

PTIX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

PTIX Stock News Headlines

April 18, 2024 | americanbankingnews.com

Protagenic Therapeutics (PTIX) vs. Its Peers Head-To-Head Survey

April 17, 2024 | finanznachrichten.de

Protagenic Therapeutics, Inc.: Protagenic Therapeutics' Innovative Peptide PT00114 to be Highlighted at Boston Summit

April 19, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

April 17, 2024 | finance.yahoo.com

Protagenic Therapeutics’ Innovative Peptide PT00114 to be Highlighted at Boston Summit

April 2, 2024 | msn.com

Protagenic Therapeutics, Inc. (NASDAQ:PTIX) Q4 2023 Earnings Call Transcript

March 27, 2024 | finance.yahoo.com

Protagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric Disorders

March 25, 2024 | finanznachrichten.de

Protagenic Therapeutics, Inc.: Protagenic Therapeutics Schedules First Q4 and FY 2023 Earnings Call

February 13, 2024 | finance.yahoo.com

Protagenic Therapeutics Achieves First Clinical Safety Milestone with its Novel Neuropeptide for the Potential Treatment of Stress-Related Disorders

April 19, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

December 17, 2023 | morningstar.com

Protagenic Therapeutics Inc PTIX

November 14, 2023 | seekingalpha.com

PTIX Protagenic Therapeutics, Inc.

October 13, 2023 | finanznachrichten.de

Protagenic Therapeutics, Inc.: Protagenic Therapeutics Announces Date of Annual Shareholder Meeting

October 13, 2023 | finance.yahoo.com

Protagenic Therapeutics Announces Date of Annual Shareholder Meeting

September 26, 2023 | finanznachrichten.de

Protagenic Therapeutics, Inc.: Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114

September 26, 2023 | finance.yahoo.com

Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114

June 17, 2023 | uk.finance.yahoo.com

PTIX - Protagenic Therapeutics, Inc.

March 24, 2023 | benzinga.com

Protagenic Therapeutics Stock (NASDAQ:PTIX), Dividends

March 22, 2023 | finanznachrichten.de

Protagenic Therapeutics, Inc.: Protagenic Therapeutics to Effect 1-for-4 Reverse Stock Split

March 22, 2023 | finance.yahoo.com

Protagenic Therapeutics to Effect 1-for-4 Reverse Stock Split

September 7, 2022 | investing.com

PTIX_old Historical Data

August 12, 2022 | finance.yahoo.com

Protagenic Therapeutics, Inc. (PTIX)

April 26, 2022 | finance.yahoo.com

Protagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th

January 20, 2022 | nasdaq.com

Protagenic Therapeutics, Inc. Common Stock (PTIX)

November 16, 2021 | finance.yahoo.com

Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update

August 30, 2021 | finance.yahoo.com

Protagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ET

August 17, 2021 | finance.yahoo.com

Protagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business Update

July 23, 2021 | marketwatch.com

Protagenic Therapeutics Updates on Patient Enrollment for PT00114 Trial, Shares Lower

See More Headlines

Receive PTIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Protagenic Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/16/2021
Today: 4/19/2024
Next Earnings (Estimated): 5/20/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:PTIX
CUSIP: N/A
CIK: 1022899
Web: www.protagenic.com
Phone: 212-994-8200
Fax: 603-761-6223
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($1.15)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-5,000,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -101.81%
Return on Assets: -82.18%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 6.41
Quick Ratio: 6.41

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.83 per share
Price / Book: 1.60

Miscellaneous

Outstanding Shares: 4,440,000
Free Float: 2,794,000
Market Cap: $5.91 million
Optionable: Not Optionable
Beta: 0.36

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Dr. Garo H. Armen Ph.D. (Age 71)
Co-Founder & Executive Chairman of the Board
Dr. Alexander Kenneth Arrow C.F.A. (Age 53)
M.D., CFO & Secretary
Comp: $150k
Dr. Andrew Slee (Age 74)
Chief Operating Officer
Dr. Robert Benjamin Stein M.D. (Age 73)
Ph.D., Chief Medical Officer & Director

Key Competitors

View All Competitors

Insiders

Alexander K Arrow
Bought 8,000 shares on 10/12/2023
Total: $6,480.00 ($0.81/share)

View All Insider Transactions

PTIX Stock Analysis - Frequently Asked Questions

How have PTIX shares performed in 2024?: Protagenic Therapeutics' stock was trading at $0.99 at the beginning of 2024. Since then, PTIX stock has increased by 30.3% and is now trading at $1.29.
View the best growth stocks for 2024 here.
When is Protagenic Therapeutics' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our PTIX earnings forecast.
How were Protagenic Therapeutics' earnings last quarter?: Protagenic Therapeutics, Inc. (NASDAQ:PTIX) released its quarterly earnings results on Tuesday, November, 16th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.03.
How do I buy shares of Protagenic Therapeutics?: Shares of PTIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PTIX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial